Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Venture Investors Health Fund (VI) was founded in 1984 as Madison Capital Corporation, with its headquarters in Madison, Wisconsin. The firm specializes in investing in healthcare innovations, managing over $350 million in assets under management. VI's mission is to improve patient lives and reshape the future of healthcare through strategic investments in pioneering healthcare solutions.
Over the years, VI has evolved to focus on early-stage investments, particularly in sectors such as pharmaceuticals, diagnostics, medical devices, and digital health. The firm has established a strong presence in the Midwest, with additional offices in Ann Arbor, Michigan, and Milwaukee, Wisconsin. VI has built a reputation for supporting companies emerging from university ecosystems, especially those associated with the University of Wisconsin-Madison and the University of Michigan.
Notable milestones in VI's history include successful exits from companies like NeuWave Medical and TomoTherapy, which highlight the firm's ability to identify and nurture impactful healthcare innovations. VI's commitment to advancing healthcare solutions positions it as a key player in the venture capital landscape.
Venture Investors Health Fund focuses on early-stage investments in the healthcare sector, targeting groundbreaking innovations in pharmaceuticals, diagnostics, medical devices, and digital health. The firm seeks to invest in companies that are addressing urgent healthcare challenges and improving patient outcomes. VI typically invests in companies that are emerging from academic institutions, particularly those linked to the University of Wisconsin-Madison and the University of Michigan.
The firm is known for its strategic approach to identifying visionary entrepreneurs and supporting bold ideas that can redefine care pathways. VI's investment strategy includes a check size range that accommodates early-stage funding needs, allowing them to provide the necessary capital for startups to develop and scale their innovations. The firm emphasizes the importance of collaboration and often engages in co-investment opportunities with other venture capital firms to maximize the impact of their investments.
Venture Investors Health Fund's portfolio includes several notable companies that are making significant strides in the healthcare sector:
These companies exemplify VI's commitment to investing in innovative healthcare solutions that address critical medical needs and improve patient care.
Jim Adox: Managing Partner with extensive experience in venture capital and healthcare investments.
Scott Button: Partner, known for his expertise in early-stage healthcare investments.
Paul Weiss: Partner with a strong background in medical technology and innovation.
David Arnstein: Partner & CFO, responsible for financial strategy and operations.
John Neis: Partner with a focus on strategic investments in healthcare.
Jenni Le: Principal, involved in sourcing and evaluating investment opportunities.
Joe Amaral, MD: Chief Medical and Scientific Officer, providing clinical insights and guidance.
Shelly Lanning: Venture Partner with a background in healthcare entrepreneurship.
Becky Hoerman: Controller, overseeing financial management.
Linda Olson: Office Manager, supporting day-to-day operations.
Submit your pitch through their website's contact form or email them directly with your deck for consideration.
In recent months, Venture Investors Health Fund has been active in publishing insights on healthcare trends, including precision medicine and advancements in autism care. These blog posts reflect the firm's engagement with current healthcare issues and its thought leadership in the sector.
Additionally, the firm has celebrated notable milestones, including successful exits from portfolio companies such as NeuWave Medical and TomoTherapy, which have made significant contributions to cancer treatment technologies.
What are Venture Investors Health Fund's investment criteria?
Venture Investors Health Fund invests in early-stage companies within the healthcare sector, focusing on pharmaceuticals, diagnostics, medical devices, and digital health. The firm looks for groundbreaking innovations that can significantly improve patient outcomes and address urgent healthcare challenges.
How can startups apply or pitch to Venture Investors Health Fund?
Startups interested in pitching to Venture Investors Health Fund should prepare a comprehensive pitch deck that outlines their business model, market opportunity, and the innovation they are bringing to the healthcare sector. While the firm does not specify a formal application process, a warm introduction through mutual connections is often beneficial.
What makes Venture Investors Health Fund different from other venture capital firms?
Venture Investors Health Fund differentiates itself through its deep focus on healthcare innovations and its strong ties to academic institutions. The firm actively seeks to invest in companies emerging from university ecosystems, particularly those associated with the University of Wisconsin-Madison and the University of Michigan, which enhances its access to cutting-edge research and talent.
What is the typical check size for investments?
Venture Investors Health Fund typically invests in early-stage companies, and while specific check sizes are not disclosed, the firm is known for providing substantial funding to support the growth of its portfolio companies.
What is the firm's post-investment involvement like?
Venture Investors Health Fund is known for its active engagement with portfolio companies post-investment. The firm provides operational support, mentorship, and access to its extensive network, which can be crucial for startups navigating the complexities of the healthcare market.
What is the firm's approach to follow-on investments?
Venture Investors Health Fund often participates in follow-on investments to support the continued growth of its portfolio companies. The firm is committed to ensuring that its investments can scale effectively and achieve their potential in the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.